Cardiology

Boston Scientific, Guidant to pay $30M settlement

The Justice Department says Boston Scientific Corp. and its Guidant subsidiaries will pay $30 million to settle allegations that Guidant knowingly sold defective heart devices that health care facilities implanted in Medicare ...

Cardiology

Implantable defibrillators lead to decrease in cardiac arrests

Implantable cardioverter defibrillators account for one-third of the decrease in cardiac arrests caused by ventricular fibrillation in North-Holland, according to research in Circulation, an American Heart Association journal.

page 4 from 5